Please enable JavaScript to continue using this application.

Compare $ANIX vs $BDTX | Chartloom

Compare

$ANIX vs $BDTX

Anixa Biosciences Inc · Black Diamond Therapeutics Inc

ANIX

Anixa Biosciences Inc

BDTX

Black Diamond Therapeutics Inc

Compare $ANIX vs $BDTX

Comparing Anixa Biosciences Inc and Black Diamond Therapeutics Inc

ANIXAnixa Biosciences Inc

BDTXBlack Diamond Therapeutics Inc

ANIXAnixa Biosciences Inc

Market cap

$99M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-8.2%

52W performance

-34.7%

FCF yield

-7.5%

BDTXBlack Diamond Therapeutics Inc

Market cap

$105M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

-26.5%

52W performance

-54.1%

FCF yield

-31.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ANIX

BDTX

Detailed metrics comparison

ANIX

Anixa Biosciences Inc

BDTX

Black Diamond Therapeutics Inc

Market Cap

ANIX$99M

BDTX$105M

Enterprise Value

ANIX$97M

BDTX$86M

Price

ANIX$2.90

BDTX$1.83

P/E Ratio

ANIXN/A

BDTXN/A

P/S Ratio

ANIX488.35x

BDTX0.00x

EV/Sales

ANIX481.69x

BDTX0.00x

EV/EBITDA

ANIX0.00x

BDTX6.96x

P/B Ratio

ANIX7.09x

BDTX1.13x

P/FCF Ratio

ANIXN/A

BDTXN/A

EV/FCF

ANIX-13.19x

BDTX-2.61x

PEG Ratio

ANIXN/A

BDTXN/A

Forward P/E (NTM)

ANIXN/A

BDTXN/A

Forward P/S (NTM)

ANIXN/A

BDTXN/A

Revenue (TTM)

ANIX$0

BDTX$0

Revenue Growth (YoY)

ANIXN/A

BDTX-100.0%

Forward Rev Growth

ANIX139.6%

BDTX533.3%

Gross Margin (TTM)

ANIX100.0%

BDTX0.0%

Operating Margin (TTM)

ANIX0.0%

BDTX0.0%

EBITDA Margin (TTM)

ANIX0.0%

BDTX0.0%

Net Margin (TTM)

ANIX0.0%

BDTX0.0%

FCF Margin (TTM)

ANIXN/A

BDTXN/A

Net Income (TTM)

ANIX$-10M

BDTX$-43M

FCF (TTM)

ANIX$-7M

BDTX$-33M

EPS (TTM)

ANIX-$0.30

BDTX-$0.74

ROE (TTM)

ANIX-7017.0%

BDTX-3880.0%

ROA (TTM)

ANIX-6780.0%

BDTX-3047.0%

ROIC (TTM)

ANIX-7017.0%

BDTX-3880.0%

Cash

ANIX$1M

BDTX$19M

Debt

ANIX$0

BDTX$0

Net Cash/Debt

ANIX$1M

BDTX$19M

Current Ratio (TTM)

ANIX8.55x

BDTX7.28x

Quick Ratio (TTM)

ANIX7.95x

BDTX6.98x

Debt/Equity (TTM)

ANIX0.00x

BDTX0.00x

Debt/Assets (TTM)

ANIX0.0%

BDTX0.0%

Interest Coverage (TTM)

ANIXN/A

BDTXN/A

Net Debt/EBITDA (TTM)

ANIX0.00x

BDTX0.00x

Beta

ANIX0.47

BDTX3.41

52W Performance

ANIX-34.7%

BDTX-54.1%

YTD Performance

ANIX-8.2%

BDTX-26.5%

% from 52W High

ANIX-46.9%

BDTX-63.0%

% from 52W Low

ANIX25.0%

BDTX14.4%

Asset Turnover (TTM)

ANIX0.01x

BDTX0.00x

FCF Yield (TTM)

ANIX-7.5%

BDTX-31.3%

Earnings Yield (TTM)

ANIX-10.5%

BDTX-40.6%

Dividend Yield (TTM)

ANIXN/A

BDTXN/A

Rule of 40

ANIX0.0

BDTX-100.0

EV/GP/RG

ANIXN/A

BDTXN/A

Ticker research

View ANIX research View BDTX research

Metric	ANIX Anixa Biosciences Inc	BDTX Black Diamond Therapeutics Inc
Market & Valuation
Market Cap	$99M	$105M
Enterprise Value	$97M	$86M
Price	$2.90	$1.83
P/E Ratio	N/A	N/A
P/S Ratio	488.35x	0.00x
EV/Sales	481.69x	0.00x
EV/EBITDA	0.00x	6.96x
P/B Ratio	7.09x	1.13x
P/FCF Ratio	N/A	N/A
EV/FCF	-13.19x	-2.61x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	-100.0%
Forward Rev Growth	139.6%	533.3%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-10M	$-43M
FCF (TTM)	$-7M	$-33M
EPS (TTM)	-$0.30	-$0.74
ROE (TTM)	-7017.0%	-3880.0%
ROA (TTM)	-6780.0%	-3047.0%
ROIC (TTM)	-7017.0%	-3880.0%
Financial Health
Cash	$1M	$19M
Debt	$0	$0
Net Cash/Debt	$1M	$19M
Current Ratio (TTM)	8.55x	7.28x
Quick Ratio (TTM)	7.95x	6.98x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.47	3.41
52W Performance	-34.7%	-54.1%
YTD Performance	-8.2%	-26.5%
% from 52W High	-46.9%	-63.0%
% from 52W Low	25.0%	14.4%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-7.5%	-31.3%
Earnings Yield (TTM)	-10.5%	-40.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-100.0
EV/GP/RG	N/A	N/A
Ticker research	View ANIX research	View BDTX research

Valuation

P/S Ratio

BDTX

0.00x

ANIX

488.35x

EV/FCF

ANIX

-13.19x

BDTX

-2.61x

Growth & revenue

Revenue Growth TTM

BDTX

-100.0%

Forward Revenue Growth

BDTX

533.3%

ANIX

139.6%

Profitability & performance

Gross Margin

ANIX

100.0%

BDTX

0.0%

ROE

BDTX

-3880.0%

ANIX

-7017.0%

FCF Yield %

ANIX

-7.5%

BDTX

-31.3%

52-Week Performance

ANIX

-34.7%

BDTX

-54.1%

Detailed metrics comparison

ANIX

Anixa Biosciences Inc

BDTX

Black Diamond Therapeutics Inc

Market Cap

ANIX$99M

BDTX$105M

Enterprise Value

ANIX$97M

BDTX$86M

Price

ANIX$2.90

BDTX$1.83

P/E Ratio

ANIXN/A

BDTXN/A

P/S Ratio

ANIX488.35x

BDTX0.00x

EV/Sales

ANIX481.69x

BDTX0.00x

EV/EBITDA

ANIX0.00x

BDTX6.96x

P/B Ratio

ANIX7.09x

BDTX1.13x

P/FCF Ratio

ANIXN/A

BDTXN/A

EV/FCF

ANIX-13.19x

BDTX-2.61x

PEG Ratio

ANIXN/A

BDTXN/A

Forward P/E (NTM)

ANIXN/A

BDTXN/A

Forward P/S (NTM)

ANIXN/A

BDTXN/A

Revenue (TTM)

ANIX$0

BDTX$0

Revenue Growth (YoY)

ANIXN/A

BDTX-100.0%

Forward Rev Growth

ANIX139.6%

BDTX533.3%

Gross Margin (TTM)

ANIX100.0%

BDTX0.0%

Operating Margin (TTM)

ANIX0.0%

BDTX0.0%

EBITDA Margin (TTM)

ANIX0.0%

BDTX0.0%

Net Margin (TTM)

ANIX0.0%

BDTX0.0%

FCF Margin (TTM)

ANIXN/A

BDTXN/A

Net Income (TTM)

ANIX$-10M

BDTX$-43M

FCF (TTM)

ANIX$-7M

BDTX$-33M

EPS (TTM)

ANIX-$0.30

BDTX-$0.74

ROE (TTM)

ANIX-7017.0%

BDTX-3880.0%

ROA (TTM)

ANIX-6780.0%

BDTX-3047.0%

ROIC (TTM)

ANIX-7017.0%

BDTX-3880.0%

Cash

ANIX$1M

BDTX$19M

Debt

ANIX$0

BDTX$0

Net Cash/Debt

ANIX$1M

BDTX$19M

Current Ratio (TTM)

ANIX8.55x

BDTX7.28x

Quick Ratio (TTM)

ANIX7.95x

BDTX6.98x

Debt/Equity (TTM)

ANIX0.00x

BDTX0.00x

Debt/Assets (TTM)

ANIX0.0%

BDTX0.0%

Interest Coverage (TTM)

ANIXN/A

BDTXN/A

Net Debt/EBITDA (TTM)

ANIX0.00x

BDTX0.00x

Beta

ANIX0.47

BDTX3.41

52W Performance

ANIX-34.7%

BDTX-54.1%

YTD Performance

ANIX-8.2%

BDTX-26.5%

% from 52W High

ANIX-46.9%

BDTX-63.0%

% from 52W Low

ANIX25.0%

BDTX14.4%

Asset Turnover (TTM)

ANIX0.01x

BDTX0.00x

FCF Yield (TTM)

ANIX-7.5%

BDTX-31.3%

Earnings Yield (TTM)

ANIX-10.5%

BDTX-40.6%

Dividend Yield (TTM)

ANIXN/A

BDTXN/A

Rule of 40

ANIX0.0

BDTX-100.0

EV/GP/RG

ANIXN/A

BDTXN/A

Ticker research

View ANIX research View BDTX research

Metric	ANIX Anixa Biosciences Inc	BDTX Black Diamond Therapeutics Inc
Market & Valuation
Market Cap	$99M	$105M
Enterprise Value	$97M	$86M
Price	$2.90	$1.83
P/E Ratio	N/A	N/A
P/S Ratio	488.35x	0.00x
EV/Sales	481.69x	0.00x
EV/EBITDA	0.00x	6.96x
P/B Ratio	7.09x	1.13x
P/FCF Ratio	N/A	N/A
EV/FCF	-13.19x	-2.61x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	-100.0%
Forward Rev Growth	139.6%	533.3%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-10M	$-43M
FCF (TTM)	$-7M	$-33M
EPS (TTM)	-$0.30	-$0.74
ROE (TTM)	-7017.0%	-3880.0%
ROA (TTM)	-6780.0%	-3047.0%
ROIC (TTM)	-7017.0%	-3880.0%
Financial Health
Cash	$1M	$19M
Debt	$0	$0
Net Cash/Debt	$1M	$19M
Current Ratio (TTM)	8.55x	7.28x
Quick Ratio (TTM)	7.95x	6.98x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.47	3.41
52W Performance	-34.7%	-54.1%
YTD Performance	-8.2%	-26.5%
% from 52W High	-46.9%	-63.0%
% from 52W Low	25.0%	14.4%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-7.5%	-31.3%
Earnings Yield (TTM)	-10.5%	-40.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-100.0
EV/GP/RG	N/A	N/A
Ticker research	View ANIX research	View BDTX research